Vulvovaginal candidiasis (VVC) is a signifi cant problem
affecting 75% of all women at least once during their life-
time [1]. Candida albicans , the causative agent in 85 – 90%
of these infections, is a commensal dimorphic fungus rou-
tinely found in the gastrointestinal and genitourinary tracts.
Exogenous factors associated with acute VVC include mod-
ulations or imbalances in reproductive hormones caused
by oral contraceptive usage, pregnancy, and hormone